2017
DOI: 10.2220/biomedres.38.189
|View full text |Cite
|
Sign up to set email alerts
|

<b>Increases in IL-33 production by fimbriae and lipopeptide from </b><i><b>Porphyromonas gingivalis</b></i><b> in mouse bone marrow-derived dendritic cells via Toll-like receptor </b><b>2 </b>

Abstract: Interleukin-33 (IL-33) is an IL-1 cytokine family member that is involved in the development of chronic inflammatory diseases and the initiation of allergic inflammation in response to pathogens. Porphyromonas gingivalis is a primary pathogen that is involved in chronic periodontitis and its bacterial components induce inflammatory responses. Dendritic cells (DCs) recognize pathogenassociated molecular patterns by expression of pattern-recognition receptors, such as Toll-like receptors (TLRs). DCs play an esse… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 25 publications
0
8
0
Order By: Relevance
“…43 However, whether the amount of IL-33 is increased in the GCF of chronic periodontitis patients is controversial. [44][45][46][47] According to in vitro and in vivo animal experiments, the expression of IL-33 can be induced by gingipain, fimbriae and lipopeptide from P. gingivalis 48,49 and might lead to alveolar bone destruction through a receptor activator of nuclear factor-κB ligand (RANKL)-dependent pathway. 50,51 IL-18 was first recognized as an interferon (IFN)-γ-inducing factor and an activator of NK (natural killer) cells and Th1 cells, which are closely related to type 1 immunity.…”
Section: Pro-inflammatory Cytokines Involved In Periodontitismentioning
confidence: 99%
“…43 However, whether the amount of IL-33 is increased in the GCF of chronic periodontitis patients is controversial. [44][45][46][47] According to in vitro and in vivo animal experiments, the expression of IL-33 can be induced by gingipain, fimbriae and lipopeptide from P. gingivalis 48,49 and might lead to alveolar bone destruction through a receptor activator of nuclear factor-κB ligand (RANKL)-dependent pathway. 50,51 IL-18 was first recognized as an interferon (IFN)-γ-inducing factor and an activator of NK (natural killer) cells and Th1 cells, which are closely related to type 1 immunity.…”
Section: Pro-inflammatory Cytokines Involved In Periodontitismentioning
confidence: 99%
“…demonstrated that TLR4-agonistic LPS derived from Porphyromonas gingivalis did not induce IL-33 expression in dendritic cells, but live P. gingivalis cells induced IL-33 [37], suggesting that P. gingivalis LPS inhibits IL-33-inducing activity in P.…”
Section: Discussionmentioning
confidence: 99%
“…They proposed that LPS recognition by TLR4 inhibits NF-κB and IRF3, the activation of which is known to mediate IL-33 expression. Additionally, Tada et al demonstrated that TLR4agonistic LPS derived from Porphyromonas gingivalis did not induce IL-33 expression in dendritic cells, but live P. gingivalis cells induced IL-33 [37], suggesting that P. gingivalis LPS inhibits IL-33-inducing activity in P. gingivalis cells. These observations suggest that TLR4 signalling inhibits IL-33 expression.…”
Section: Discussionmentioning
confidence: 99%
“…The role of IL-33 in periodontitis remains controversial. IL-33 and ST2 expression are increased in periodontic regions in both humans and mice (Malcolm et al, 2015;Lapérine et al, 2016;Tada et al, 2016), apparently reflecting enhanced expression by oral epithelial cells (Tada et al, 2017;Papathanasiou et al, 2020). In vitro, IL-33 promotes osteoclast (OC) differentiation from human monocytes and peripheral blood mononuclear cells, even in the absence of receptor activator of nuclear factor kappa-B ligand (RANKL) (an OC differentiation factor) (Mun et al, 2010;Eeles et al, 2015).…”
Section: Introductionmentioning
confidence: 99%